Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC)

Fig. 4

Upregulation of hsa_circRNA_103809 promoted cisplatin-resistance in CS-NSCLC cells. a-c Cell proliferation abilities were examined by using the CCK-8 assay. d-f Cell viability was evaluated by performing the trypan blue staining assay. g Cell apoptosis was determined by using the Annexin V-FITC/PI double staining assay. (Note: “Control: without vectors transfection and cisplatin treatment”). Each experiment was repeated at least 3 times. *P < 0.05

Back to article page
\